Using a combination of physiological and treatment information from neurological ICU data-sets, adherence to traumatic brain injury (TBI) guidelines on hypotension, intracranial pressure (ICP) and cerebral perfusion pressure (CPP) is calculated automatically. The ICU output is evaluated to capture pressure events and actions taken by clinical staff for patient management, and are then re-expressed as simplified process models. The official TBI guidelines from the Brain Trauma Foundation are similarly evaluated, so the two structures can be compared and a quantifiable distance between the two calculated (the measure of adherence). The methods used include: the compilation of physiological and treatment information into event logs and subsequently process models; the expression of the BTF guidelines in process models within the real-time context of the ICU; a calculation of distance between the two processes using two algorithms ("Direct" and "Weighted") building on work conducted in the business process domain. Results are presented across two categories each with clinical utility (minute-by-minute and single patient stays) using a real ICU data-set. Results of two sample patients using a weighted algorithm show a non-adherence level of 6.25% for 42 mins and 56.25% for 708 mins and non-adherence of 18.75% for 17 minutes and 56.25% for 483 minutes. Expressed as two combinatorial metrics (duration/non-adherence (A) and duration * nonadherence (B)), which together indicate the clinical importance of the non-adherence, one has a mean of A=4.63 and B=10014.16 and the other a mean of A=0.43 and B=500.0.
INTRODUCTION
Across many fields of clinical medicine guidelines are used to inform and develop best practice. In order to make sure that these guidelines are being followed correctly and effectively, there are a variety of methods to monitor compliance. Common current methods to do this include post-hoc surveys that form the core data for research papers, or regular meetings after a hospital shift (or similar) to discuss different cases where perhaps the guideline was not adhered to, or negative outcomes were potentially avoidable.
Nearly all current methods have two features: qualitative evaluation and a long time-lag where the results of the surveys or discussion can find their way back into either local best practice, or can be submitted to multi-centre evaluations for the further development of the guidelines themselves. Whilst useful, it is very often the case that these features do not make full use of the data and technology that is now available to many fields of clinical medicine. A potential advantage of using such data and technology would be quantitative evaluations (e.g. an adherence rate of 67%) and rapid feedback of non-compliance to guidelines.
This work attempts to leverage those advantages by providing a "near real-time" ability to monitor clinical guideline adherence, as well as providing measurable quantitative feedback. Using data and technology currently available, the goal of this research is to express the structure of physiological and treatment patient data in such a way that can be immediately compared against bestpractice text guidelines. The results are broadly grouped into two categories, each representing a real-life clinical scenario: ▪ Minute-by-minute data: where immediate feedback would be provided indicating the level of adherence in that moment ▪ Per pressure event: where retrospective guidance on adherence could provide information on the best way to manage individual pressure events given a patient's particular clinical context
The technical approach adopted to achieve these goals is a combination of the following: the expression of the two data types (physiological and treatment) into a simplified process model; the expression of the relevant text guidelines into a comparable structure; a distance between these two models is then evaluated using similarity calculations taken from the domain of business process model comparisons (Dijkman et al. 2009 ).
MOTIVATION
There are two main areas that provide the relevant background to this work: the nature of data within critical caretraumatic brain injury (TBI) in particularand the detail of the technology chosen to support the solution of automated guideline adherence.
Critical Care Data
In the fields of medicine that involve critical caretraumatic brain injury (TBI) as an exampletechnology has advanced throughout the late 20 th and early 21 st centuries to the point where nearly every modern intensive care unit (ICU) in the developed world has a multitude of high frequency data streams available, which can closely capture the actual application of clinical interventions and the time-varying physiological response of patients. The technologies that enable this output of raw data are well established, and the economics of data storage make retention of large volumes for extended periods a feasible option. However, the key to establishing the integrity of that data for a specific purposewhether it is a study as large as a multicentre randomised controlled trial (RCT) or something more modest such as an audit of local clinical practicesis to monitor that raw data and understand the relationships between clinical treatments and physiological output.
This involves understanding that relationship at a level "above" the numbers that are output from bedside machines (other terminology may similarly describe this idea as observing data at a higher "layer of abstraction"). The actual physiological output shows a series of numbers, which without proper context can mean very little, but which, with appropriate surrounding information, could be formed into structures that do have clinical meaning (e.g. an "adverse event" such as a sudden spike in blood pressure would be represented by a particular combination of systolic and diastolic blood pressure numbers). When this is combined with clinical treatment information (e.g. the time and dose of a bolus of Noradrenaline) then patterns of clinical behaviour and patient response can be built up.
If the algorithms used to represent these patterns of information are valid, thendue to the proximity of this data representation to the sourceit is likely that it will be a highly accurate description of what happens in an ICU. And therefore in theory, it would be possible for a system to work outempirically from sourcewhether a specific clinical process in the ICU has been followed or not.
Very often, the most important and highlyvalued process within any clinical field is that of the official guidelines compiled and peer-reviewed by domain experts. Therefore an automated process to measure adherence to these guidelines would very likely be welcome due to the information it could provide on procedure, compliance and base-line information for studies to either build upon or challenge those guidelines. For instance, questions that could be asked of the system could be: 1) "Has a particular protocol or guideline been applied correctly?" (to audit local compliance) 2) "Does a particular guideline recommendation actually work?" (use outcome versus compliance data to provide information to a wider study)
Whilst it is hoped that solutions to this type of guideline adherence measurement could be applied to critical care generally, the area of traumatic brain injury (TBI)and within TBI specifically the management of intra-cranial pressure (ICP) and cerebral perfusion pressure (CPP) -has many features that make it a good candidate for study: the condition is complex and therefore suffers from large uncertainties in official guideline compilation and compliance (Bullock et al. 1996) ; it is also an environment that heavily uses modern technology to provide high-resolution neuro-ICU physiological and clinical treatment data streams (Piper et al. 2009 ); and the seriousness and prevalence of the condition (www.headway.org.uk) means that any advances in the field have the potential to make a large and positive impact on the population.
Applied Technology
Based on the considerations above concerning critical care data, the general technical data requirements to achieve this can be identified as follows: ▪ High resolution physiological patient data ▪ Accurate and comprehensive treatment data ▪ The ability to combine these into a formalised process expression ▪ The ability to compare this formalised expression with other similar entities (such as guidelines, study protocols, institutional procedure, etc)
Whilst the pool of potential technological solutions for this type of problem space is large, the following criteriaafter accuracy and validitywere deemed the most important when choosing a solution: ▪ Simplicity of implementation ▪ Minimising points of "assumed knowledge" ▪ Correspondence of solution output with real clinical situations ▪ The ability to inhabit a real clinical work-flow "invisibly"
After researching different technologies that potentially meet these criteria, the following combination of processes was put together as a framework: ▪ The classification of events in physiological output known as EUSIG events (Edinburgh University Secondary Insult Grade) (Jones et al. 1994) , and compilation of an event log from this ▪ The expression of those event logs as process models ▪ The extraction of clinical guideline texts into process models ▪ The comparison of two process models using complex similarity/distance algorithms Together, these processes form the framework through which the possibility of quantitative, realtime guideline adherence monitoring can be explored. Figure 1 shows a high-level schematic of the framework steps to convert ICU data and guideline text into comparable data-sets.
Examining these processes in more detail, event detection and representation are common methods of data analysis in medicine. The classification of pressure events using EUSIG parameters has a well-established precedent, particularly in the field of TBI (Jones et al. 1994) . The central idea behind this step is that an event can be classified as having several EUSIG "parameters" e.g. event hold-down, threshold, durationthen this pattern is searched for in the physiological data. Once an event is found, a time-window is laid over it and clinical treatment events are searched for (figure 2 shows a schematic of a EUSIG event pattern). The full detail of the conversion of the data-sets used in this work from raw physiological and treatment output to their corresponding event logs can be found in (Stell et al. 2014) . The other components of the framework concern the use of process models, which are a construct borrowed from the field of business process managementmost commonly used to describe real-world problems of project management and corporate efficiency. There have been projects where process models have been applied to medical problems, but these appear to mainly concern the administration and logistics of hospitals and other large-scale corporate structures (where the fact that these structures are medical in nature is largely incidental).
Similar in nature to flow-charts, a process model is a directed or undirected graph with a collection of edges and nodes. They can be expressed using various notations, each with slightly different characteristics -e.g. UML (www.uml.org) or BPMN (Chinosi & Trombetta 2012 ). Depending on the notation used, the edges and nodes represent various actions and states that can be generalised to the specific context being described (in this case, the medical output observed from a neurological ICU bedside machine).
The translation to a process model in this work comes from two sources: evaluation of an event log for the physiological/treatment data and the evaluation of semantic text from the guideline. This latter source is a manual step in this work, and is similar to the work of "semantic web" interpretations of medical text information (Kaiser & Miksch 2009 ). Comparison of the two resulting process models builds on the work conducted in (Dijkman et al. 2009 ), with the notions of similarity encapsulated by the similarity of individual nodes and edges combined with relevant weighting to represent the significance of certain aspects.
To apply these business process analysis toolsexpression of medical output as process models and the use of comparison and distance calculations in this contextin this particular way are believed to be a unique feature of this work.
RELATED LITERATURE
A review of related literature covers several areas: issues of adherence to clinical guidelines in general and specifically in the TBI domain, novel attempts to improve adherence, and the relevance and utility of the chosen technology.
Clinical/TBI Guideline Adherence
Issues of communication appear as a common thread when evaluating adherence to clinical guidelines. (Ansari et al. 2003 ) looked at beta-blocker use in heart failure and showed various methods and channels of disseminating the guideline information.
These were to use a nurse facilitator (direct intervention by trained specialist), general education (documents, leaflets, etc) and clinical reminders (automated interventions). These all had different effects on adherence, with the nurse facilitator being the most successful. (Rood et al. 2005) indicated that a study of glucose measurement and regulation improves greatly when dissemination is provided through computer-assisted means rather than through paper-based means.
A systematic review of guideline dissemination strategies (Prior et al. 2008) showed that the (non-) effectiveness of passive dissemination is a significant result. Similar to the (Ansari et al. 2003 ) study, where direct intervention is taken by a person or automated method, the adherence rate is markedly better than if the guideline document and information is published passively (e.g. using conferences, websites or didactic lectures).
Other studies (Grol 2016 ) similarly show that targeted and behaviourally "disruptive" methods are best for disseminating information and influencing clinical practice. Therefore, understanding the effectiveness of these different methods of dissemination is an important factor in developing tools to improve awareness and therefore adherence.
When considering TBI specifically, the gold standard in guidelines is the 1994 Brain Trauma Foundation (BTF) initiative to formulate treatments for brain injury, which have since become standardised, internationally-recognised guidelines (Bullock et al. 1996) . Several studies have been conducted that show dropping mortality rates and improved long-term outcomes since the adoption and spread of use of these guidelines (Bratton & Chestnut 2006) . In the last decade, this improvement in TBI management has continued, leading to studies indicating that overall improvements in outcome due to adherence to the BTF guidelines have also been apparent (Tarapore et al. 2016 ) and in similar studies conducted four years apart (Ghajar 2000) and (Fakhry et al. 2004 ).
However, significantly, adherence to the BTF guidelines is not universalmany studies outline their potential deficiency in various aspects such as hypothermia (Clifton et al. 2001 ) and the need for ICP monitoring (Chesnut et al. 2012 ).
Novel Attempts to Improve Adherence
Evident from this discussion is the fact that guideline adherence is subject to great variation. There are many reasons for non-adherence, but these can be broken down into two broad categories: being unwilling to adhere to a guideline and being unable to adhere. Whilst techniques to address the first category include improved dissemination, communication and various long-term social methods, improvements in the second category, which is usually functional in nature (e.g. lack of resources/time), can be approached using "behaviourally disruptive" methods.
Most attempts to improve adherence to guidelines in the medical domain involve a direct change or implementation of a care procedure. In these cases, the evidence-base for a guideline comes from a panel of experts in the field that have reached a point of consensus for various treatments. The novel attempts then concern the implementation of that guideline in patient care in a standardised and accountable way.
A campaign that exemplifies this approach is "Surviving sepsis", which has looked at targeted improvement of patient care by specifically supporting guideline adherence through the identification of resuscitation and management "bundles". Part of this was an intensive data collection arm, whichin real-timeforced clinicians to systematically add data as part of clinical routine (Levy et al. 2010 ). The results of this have shown a marked improvement in adherence to the guidelines, but an emergent complication was the ability to stay current with the latest guidelines and update procedures to reflect this. Feedback from the first four years of this project back into the redevelopment and improvement of sepsis guidelines has been cautiously optimistic (Dellinger et al. 2013) . Whilst not specifically providing a new type of analysis it does provide a large canon of data for a specific condition that is potentially useful for future studies into sepsis as well (Lehman et al. 2011) .
A study looking at the ability to change behaviour where possible when implementing guidelines (Grol & Grimshaw 2003) , has shown that only comprehensive interventions on all levels of input and with specific targets and barriers identified stand a chance of influencing behaviour. Several categories were identified: educational strategies, audit and feedback, use of reminders/computers, substitution of tasks, multi-professional collaboration, mass media campaigns, total quality management, financial incentives, patient-mediated interventions, and a combination of all of these interventions. This was a broader conclusion than that reached by (Ansari et al. 2003 ) on a similar study (which described active rather than passive interventions being more effective). Improvements in mobile technology have also further advanced the ability to implement guideline adherence, as the proximity to the end user (be they patient or clinician) allows immediate and real-time intervention or consultation. Examples of patient interventions include the development of the MobiGuide project (Shalom et al. 2015) , and other quality of life applications that allow quick reference in the form of either notifications (e.g. a message to a patient to take their medication) or input (e.g. a daily symptom diary that a patient can fill in) which allows the direct consequences of adherence or nonadherence to be measured. An example of adherence improvement tools directed at clinicians include the development of the SIGN apps (www.sign.ac.uk/sign-apps.html), which provide immediate triage information across many emergency fields, allowing doctors to quickly consult their actions with regard to the official guidelines in this field.
Framework Technology
It can be seen that many novel technologies exist, but for the purposes of choosing an applicable technology to address the particular challenges in this work, many of the characteristics appear to be well represented by processes and work-flows, and hence the slightly wider speciality of process models.
(Perimal-lewis et al. 2012) claims that the fundamental element required for the construction of a process model is the historical event log of a process, and this lends itself to the description of actions and reactions in a medical context. This research area is referred to "process mining" and is usually applied to the logistical higher-level patient care work-flows within a hospital. Studies, such as (Mans & Schonenberg 2009 ), investigate the different management processes using various process mining views on control-flow structures, and how these affect organisation and performance within a hospital.
This area is also related to the more general domain of business process management (BPM) not usually realized as medical processes, but critical in the use of event/reaction flow-diagrams to formally describe processes that occur within complex organisations. An example of this is (Werf et al. 2012) , which looks at tools to automate the compliance of an business to specific guidelines, typically referred to as "audit". The idea behind this work is to develop an awareness of the context of a process, which can often impact the perceived compliance to a guideline, without being sufficiently accounted for in the evaluation. Work such as this however, does tend to exist in abstract discussions, and rarely gets implemented in a real hospital setting.
There is also a discrepancy between the level of pattern extraction and the focus on the level of patterns. The process mining work referred to above nearly always focuses on the clinician behaviour as part of a corporate body, with a view to improving those corporate processes such as (Perimal-lewis et al. 2012) . At a lower "micro" level, pattern extraction science focuses on mathematical techniques to detect individual events (again, similar to and possibly driven by signal processing). The connection between these two levels, which is where the work proposed in this document is focused, is rare, though it does exist. (Huang et al. 2012 ) looks at the "clinical pathway" area, where a clinical event log is analysed and common remedial medical behaviours are extracted. The work was validated by clinical experts as a true representation of some of their behaviours, but it did conclude that the general nature of the conclusions, meant that more specific work was required, and that some critical behaviours were missed. This is where the focus on a specific condition helps in identifying processes more exactly and in a way that is immediately useful to clinicians working in the ICU.
SYSTEM ARCHITECTURE
The highest level schematic of the proposed technical solution in this work can be seen in figure 1 (section 2.2). This shows the broadest steps to achieve a measure of guideline adherence: 1. Convert the raw physiological and treatment data into an event log 2. Convert the event log into a process model 3. Convert the text guidelines into a similarly structured process model 4. Compare the two and calculate the distance between them (this is the measure of noncompliance, the inverse of which is adherence, the overall goal)
The architectural and design details are now expanded upon in this section.
Process Model from Physio/Treatment Data
The conversion of the physiological and treatment data into a set of event logs has been conducted using the EUSIG event parameter definitions. As mentioned in section 2.2, the major detail of this work for one of the data-sets used here can be found in (Stell et al. 2014) .
In summary, the work was an audit of pressure events (specifically ICP and CPP) through-out the Brain-IT data-set ) (see section 5 for a summary description of this data), using pattern matching techniques where the EUSIG definition of ICP or CPP event was the target pattern within the data-set (for all pattern definitions the structure was the samesee figure 2but the parameter values, such as threshold and hold-down time were varied). The overall results of this conversion work outlined some interesting clinical results, such as the verification of an "unofficial" event threshold of 15 mmHg when clinicians feel they must intervene to manage an escalating ICP (also known as an intracranial hypertensive episode). But the practical data output was a generalised accumulation of information about ICP and CPP events, alongside treatment information.
After this audit work had been concluded, the next logical step was realised in storing this data representation in a standardised interface, so that future data-sets could be compared in a similar way. Currently this standardised interface is implemented in a MySQL database (known as the "treatment profile" database), the entity-relationship diagram (and hence schema) can be seen in figure 3.
From this "treatment profile" database, a logical representation of an event log can be drawn, which will then be converted into a process model. (Note: when considering the definition of an "event" in the terms supporting the development of a process model, the log actually encompasses both the pressure events and the application of treatments).
The implementation of the process models involved at this stage can be considered as a set of elements indicating an "event" taken at any one time (the most useful temporal measure deemed to be minute-by-minute). So using a combination of the event, any treatments falling within the time window, a "guideline object" is created that indicates what those elements are at a given minute due to the actual actions that have occurred in the ICU. In the next section a similar set of objects are constructed, which form the ideal actions that would have occurred if the guidelines had been followed exactly.
Process Model from Guidelines
The conversion of BTF guidelines to a process model requires more manual interpretation and implementation than the conversion from the ICU data. Some semantic processing technologies were considered to achieve this, but were considered unnecessary once the specific guidelines were listed, as the conversion process turned out to be relatively simple. There are 15 severe traumatic brain injury guidelines (for severe in-hospital treatment) covering various types of injury and treatment (www.tbiguidelines.org). Of these, the four that were specifically looked at (due to their relevance to the management of ICP and CPP) were: ▪ #1 -Blood pressure and oxygenation ▪ #2 -Hyperosmolar therapy ▪ #8 -Intracranial pressure thresholds ▪ #9 -Cerebral perfusion thresholds An example of text that required translation was guideline #9 which had several conditions relating to the threshold of CPP where treatment must be applied, dependent on the presence (or not) of cerebral autoregulation (the feedback mechanism that protects the brain for a limited time when blood flow is impaired). The guideline text reads: ▪ "Aggressive attempts to maintain cerebral perfusion pressure (CPP) above 70 mm Hg with fluids and pressors should be avoided because of the risk of adult respiratory distress syndrome (ARDS)" ▪ "CPP of <50 mm Hg should be avoided" ▪ "The CPP value to target lies within the range of 50-70 mm Hg. Patients with intact pressure autoregulation tolerate higher CPP values" ▪ "Ancillary monitoring of cerebral parameters that include blood flow, oxygenation, or metabolism facilitates CPP management"
When converting this to a process model, the model was chosen to be expressed in business process model notation (BPMN). Figure 4 shows how these text bullet points translate to this notation. Similar BPMN diagrams were compiled for the other guidelines (#9 being the most complex) and then related to the process model drawn from the raw ICU data.
In terms of how the information from the physio/treatment stream relates to this example, the most important information captured is the presence of a threshold-crossing in the CPP read-out. This indicates the beginning of a CPP pressure event and the start of the cycle denoted in figure 4. Ancillary monitoring and autoregulation status are stored in other clinical monitoring parameters, with the treatment applied stored in the treatment profile database. The treatment profile database is searched for this combination of event and treatment. The red box in figure 4 denotes a detail about the type of treatment: if the patient is highly loaded with pressors already then a water treatment is mandated, as well as vice versa. Therefore the process model checks for the type as well as the presence of a treatment.
The process models are therefore compiled by listing the relevant nodes and graphs (e.g. treatment presence, type, and response time and their sequence in time in relation to each other). To re-state again: one is generated for the actual timeline from the treatment profiles database, which is a model representing what happened in the ICU. And the otherdrawn from the guideline -represents the ideal timeline and shows what the ideal clinical response would have been given the context of events, patient situation, etc.
Similarity Calculations
These two process models can now be compared, and the distance calculation chosen builds on the work conducted by (Dijkman et al. 2009 ). In this paper a distance between two business process models is calculated using several different algorithms and representations of the models themselves. The fundamental calculation presented comes down to a weighting attached to the different nodes and edges, then a calculation of how many transitions the first model needs to make in order to reach the same state as the second model. The different distances calculated include string-edit distance (nodes only) and graph-edit distance (nodes and edges). The distances between the process models presented are calculated using four different algorithms, each with different characteristics that trade-off between completeness and efficiency: "Greedy", "A-star", "Process heuristic", "Exhaustive". The conclusion of the paper is that the "Greedy" algorithm (searching for local optima) and "A-star" (a well-known shortest distance algorithm) were the best performing in terms of speed versus acceptable completeness ("A-star" being slightly slower but more accurate).
To build on and apply these methods to the guideline adherence work in this paper, the simplest methods were initially chosen, corresponding to the "string-edit distance" used in (Dijkman et al. 2009 ). These include two algorithms which have a simple direct comparison with no weighting added to the nodes ("Direct") and one with node-weighting added ("Weighted").
Clinical Result Presentation
Using these distance calculations, the final number of adherence is generated. They are presented in two categories: level of non-adherence (expressed as a percentage) and the duration of these levels of nonadherence (in minutes). However, to apply real clinical relevance to these numbers, the factors must be considered in combination. Figure 5 shows a square with four quadrants indicating severity when considering non-adherence level against duration, similar to those used for risk analysis. In the bottom left quadrant, we have deviations that are of a low level for a short time (the least significant clinical scenario). In the top right, are deviations that are of a high level for a long time (the highest significance). The opposing quadrants indicate a mid-range of significance. Therefore two combinatorial metrics indicate approximately where on this quadrant the output sits:
The clinical analogue of these combinations is that if A is very high or very low, the severity occupies either of the two mid-range quadrants. If A tends to 1, then it is either in the least or most significant quadrants. To ascertain which of these latter quadrants the output occupies, B indicates either high (most significant) or low (least significant). Testing where the thresholds of these limits occur will be follow-up work (see discussion section). 
RESULTS
The results in this section show the adherence output when the system is run against a real neurological ICU data-set. The data-set is the Brain-IT database : a compilation of 262 brain-injured patients collected over a period of three years from 2003-2006, across 22 specialist neurological ICU centres in Europe.
Output corresponding to the two clinicallyrelevant categories is shown: non-adherence measurements on a minute-by-minute basis over single pressure events and aggregate information about non-adherence and duration over all pressure events occurring in individual patient stays.
The relative weightings used for non-adherence factors are: 0.25 for repeat pattern treatment nonadherence, 0.5 for a type non-adherence and 1.0 for treatment outside the time window.
Minute-by-minute
The clinical analogue to measuring adherence on a minute-by-minute basis would be that of a real-time monitor, allowing a clinician to know immediately where the patient's clinical context lies in relation to the official guideline. In the framework built for this work an example of this output is shown in figure 6. Figure 6 : Minute-by-minute read-out of guideline adherence for a single pressure event on one patient using the direct algorithm.
In this example the time-window of response mandated by the guideline is 15 minutes as an acceptable clinical response time. In figure 6 the blue line indicates the trace of physiological series (in this case mean ICP), with flags indicating treatments administered by the clinician during the course of the event. The red line indicates the nonadherence level at that immediate minute. It can be seen that two non-adherence values dominate the red line: 25% and 50%. The total output for this patient all events, therefore more than the single event shown in figure 6is shown in tables 1 and 2 (corresponding to the use of the direct and weighted algorithms respectively). In both tables, the reasons that make up these non-adherence values are two-fold: "Treatment should be part of a repeat pattern" and "Treatment not administered within time window". The difference between the two tables relates entirely to the numbers resulting from the different scales assigned to each reason. Therefore with a factor 0.25 assigned to the repeat pattern treatment, the levels of non-adherence skew in either direction (the lower number decreases significantly from 25% to 6.25%, whilst the higher number increases slightly from 50% to 56.25%). To develop this as a useful clinical tool, would require a survey of domain experts to find a common consensus on what weighting values should be attached to each reason. Or expressed another way: how important is each reason in relation to each other? Also notable between tables 1 and 2 is that the structural information output remains unchanged (the duration size and the number/nature of the nonadherence reasons). This intuitively makes sense as the only difference between the two algorithms is one of scale due to the differently weighted factors. As the work develops to include distance calculations between edge directions as well as node size, it is anticipated that there may be structural differences to evaluate (see discussion section). Table 3 shows another patient that has similar non-adherence levels due to the dominant factors of treatments outside of the time window and repeat patterns. However, there is an additional factor of "treatment type contraindicates in patient context", which adds a different number to the deviation amount (in this case 18.75%, as treatment type has a weighting of 0.5). This has come about as the patient has been administered steroids when the load is already high, which is an aspect that this guideline (#9) mandates against.
Single Patient Stay
The second category to consider is the nonadherence levels over an entire patient stay. The clinical utility of this is to gain an understanding of how non-adherence relates to the management of individual pressure events given a patient's clinical context. To this end aggregated output is compiled for the individual patients. Total information for patients 15026161 and 26138384 are already shown in tables 1, 2 and 3 but more detailed statistics on the non-adherence and duration for each patient (using the "weighted" algorithm) are shown in tables 4 and 5. For each of these patients, an inter-quartile range is calculated to understand the range and spread of the data. An obvious point of interest from the nonadherence level is how much the non-adherence level skews towards the maximum level of 56.25% Table 4 : Spread and central tendency calculations for nonadherence level, duration, duration/non-adherence (A), and duration * non-adherence (B) using the "weighted" algorithm for patient 15026161.
The clinical interpretation of these results is potentially broad, but a first step is to check the mean values against the quadrants outlined in figure  5 . For patient 15026161, the duration/non-adherence (A) is 4.63 and the duration * non-adherence (B) is 10014.06. Assuming both of these figures to be considered "large"which in the case of A means that the ratio is significantly higher than 1would put the overall impact of these deviations into the mid-range quadrant close to the border of "most significant". When looking at the detailed output of individual deviations, this could be interpreted as the analogue of many "small" deviations (due to the non-administration of treatments in timely manner) adding up to a significant impact on management of ICP events. Table 5 shows a similar table for the patient 26138384, where the mean value of (A) is significantly lower than a ratio of 1 and the mean value is an order of magnitude lower than 15026161 therefore the relative non-adherence potentially indicates a lower impact. Table 5 : Spread and central tendency calculations for nonadherence level, duration, duration/non-adherence (A), and duration * non-adherence (B) using the "weighted" algorithm for patient 26138384.
DISCUSSION
The output of the spread and central tendency information in the interquartile range tables (4 and 5) indicate the dominance of a particular set of nonadherence reasons ("treatment not administered within time window" and "treatment not part of repeat pattern"). This is very likely due to the low annotation level of this data-set, which in turn is linked to the age of the data-set (itself a pioneering effort in neurological ICU data collection at the turn of the millennium). The next step in this research is to run the same validation test over several more modern data-sets, three of which have been identified and will be available for further work very shortly (the CSO project data for the identification of artefactual data in neurological ICUs, the ICCA system data from the Queen Elizabeth University Hospital ICU, Glasgow, and MIMIC III (Saeed 2007) ). These are similarly representative of different aspects of the neurological ICU -CSO indicates a physical check on treatment information supplied by computer (an observer notes whether a treatment was actually delivered at the time the computer indicates), ICCA is one of the latest software frameworks in neurological ICUs, and MIMIC III is a compilation of data from 2008 to 2013 on non-specialist ICU information from around the USA. Not only will the output of using these data-sets provide further valuable information on the validity of the approach in this paper, but will provide accuracy checks of different steps along the process of compilation.
Similarly, a consensus check against domain experts will be performed in order to match the output from this work against what is considered "typical" reactions in a neurological ICU. From this comparison, it would be hoped that the notion of scaling of the weighted nodes would give an indication of how important the different clinical factors are and how this affects the quantitative output when combined with other factors. An indication of the thresholds on figure 5 indicating the difference between different regions of severity could be ascertained through a similar process. An interesting study would be a real-time output of a clinician (e.g. recording a verbal commentary of actions taken as they are occurring) to compare against the evaluation occurring in the work. However the difficulties of achieving enough data beyond a small sample for this type of studydue to privacy and ethical concernsmay be too challenging.
Another strand that will be expanded on shortly will be the usage of the more sophisticated distance comparison algorithms posited by (Dijkman et al. 2009 ). It is assumed that structural distance calculations -"graph-edit similarity" in the language of that workwill affect the structural output of the non-adherence and duration, which would be visible in the results for a single patient run over several different algorithms. The statistical significance of this difference will be calculated then verified against the experience of domain experts.
Finally, whilst the output can guide real-time immediate clinical reaction, and give information on pressure event management, it is hoped that with the same metrics taken over all patients in all data-sets, and linked to clinical outcome, the quantitative measures of non-adherence could inform studies that contribute to official guideline development. This work is currently underway and makes use of the (highly unusual) aspect of the Brain-IT data-set capturing patient outcome, measured using the Glasgow Outcome Scale, at 6-months post-injury.
CONCLUSIONS
Presented in this work are the preliminary results from an automated system constructed to use data that is currently available in many high-dependency neurological ICUs. The central framework uses simple process model technology to interpret data from two sources (bedside physio/treatment data and text guidelines) and use these to compare and add quantitative value. The output presents information in a variety of ways to gain detailed insight into the duration and nature of non-adherence to mandated guidelines that has the potential to aid immediate real-time clinical response, as well as aggregated study information to provide feedback on pressure event management.
